期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

慢性心力衰竭患者心肾综合征的分级治疗 被引量：5

下载PDF
导出
摘要 目的对慢性心力衰竭(CHF)患者发生的心肾综合征(CRS)进行临床分级治疗。方法 365例CHF患者中的168例进行Ⅰ级基础治疗,Ⅱ级强化治疗,Ⅲ级血液净化肾脏替代治疗。结果 CRS肾功能轻、中度损伤的患者,采用Ⅰ、Ⅱ级治疗后,总有效率分别为97.5%和90.3%,显著高于肾功能重度损伤和尿毒症期的81.9%和46.2%(χ2=37.71,P<0.01)。在尿毒症期患者中,有15例实施Ⅲ级肾脏替代治疗,其中9例抢救成功,6例死亡。结论 CRS患者在常规积极治疗原发病的基础上,根据肾功能损伤程度,有针对性地采取分级治疗可明显改善心肾功能。
作者 黄慧俐 郝杰 俞洋 兰平起 胡建军 李莉 李霁峰 王琨
机构地区 解放军第二炮兵
出处 《中华保健医学杂志》 2012年第2期148-150,共3页 Chinese Journal of Health Care and Medicine
关键词 慢性心力衰竭 心肾综合征 分级治疗
分类号 R541.6 [医药卫生—心血管疾病] R692.5 [医药卫生—泌尿科学]
  • 相关文献

参考文献8

  • 1Shlipak MG. Pharmacotherapy for heart failure in patients with renal insufficiendy[J].Annals of Internal Medicine,2003.917-924.
  • 2李静,李新立,顾凯,张海锋,徐芳,周艳丽,周蕾,徐东杰,叶行舟,智宏,曹克将.扩张型心肌病心力衰竭患者心肾功能相互关系的研究[J].临床心血管病杂志,2010,26(2):104-108. 被引量：26
  • 3McAlister FA,Ezekowitz J,Tonelli M. Renal insufficiency and heart failure:prognostic and therapeutic implicationg from a prospective cohort study[J].Circulation,2004.1004-1009.doi:10.1161/01.CIR.0000116764.53225.A9.
  • 4陈再英;钟南山.内科学[M]北京:人民卫生出版社,2008170549.
  • 5Knight EL,Glynn RJ,Mclntyre KM. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy:results from the studies of left ventricular dysfunction (SOLVD)[J].American Heart Journal,1999,(5 Pt 1):849-855.doi:10.1016/S0002-8703(99)70009-8.
  • 6Neuberg GW,Miller AB,O＇ Connor CM. Diuretic resistance predicts mortality in patients with advanced heart failure[J].American Heart Journal,2002,(1):31-38.doi:10.1067/mhj.2002.123144.
  • 7Bayliss J,Norell M,Canepa-Anson R. Untreated heart failure:clinical and neuroendocrine effects of introducing diuretics[J].British Heart Journal,1987.17-22.doi:10.1136/hrt.57.1.17.
  • 8Kittleson M,Hurwitz S,Shah MR. Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality[J].Journal of the American College of Cardiology,2003,(11):2029-2035.doi:10.1016/S0735-1097(03)00417-0.

二级参考文献15

  • 1王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2008.1746-1759.
  • 2JAMESON J N, KASPER D L, HARRISON T R, et al. Harrison's principles of internal medicine[M]. 16th ed. New York: McGraw-Hill Medical Publishing Division,2005 : ISBN 0--07-- 140235 -- 7.
  • 3PIMENTA J M, ALMEIDA R, ARAUJO J P ,et al. Amino terminal B-type natriuretic peptide, renal function, and prognosis in acute heart failure: A hospital cohort study. J Cardiac Fail, 2007, 13, 275--280.
  • 4CODD M B, SUGRUE D D, GERSH B J, et al. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy: a population based study in Olmstead county[J]. Circulation, 1989,80 : 564- 572.
  • 5MIURA K, NAKAGAWA H, MORIKAWA Y, et al. Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey [J].Heart, 2002,87 : 126 -- 130.
  • 6SILVERBERG D, WEXLER D, BLUM M, et al. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both the cardiac and renal function and reduce hospitalization[J]. Clin Nephrol, 2003, 60(Suppl 1) : S93--S102.
  • 7HEYWOOD J T. The eardiorenal syndrome., lessons from the ADHERE database and treatment options [J].Heart FailRev,2004, 9: 195--201.
  • 8RONCO C, HAAPIO M, HOUSE A A, et al. Cardiorenal syndrome[J]. J Am Coll Cardiol, 2008,52 : 1527 --1539.
  • 9ROBB K, JOSEPH R, ANDREW S. Organ cross talk in the critically III: The heart and kidney[J]. Blood Purif, 2009,27 : 311 -- 320.
  • 10RITZ E, FOLEY R N. Cardiovascular risk factor [M]//DAVISON A M, CAMERON J S, GRUNFELD J P, et al. Oxford Textbook of Clinical Nephrorogy. 3rd ed. Oxford: Oxford University Press, 2005: 3--5.

共引文献25

同被引文献44

  • 1贾凤玉,孟建中,荣鹏,王素霞,景颖,葛彦明,岳冀.连续性血液净化救治危重心肾综合征对患者预后的影响[J].中华临床医师杂志（电子版）,2011,5(15):4390-4393. 被引量：12
  • 2金争鸣,胡晓晟,陈君柱,胡申江,张芙荣.慢性心力衰竭患者早期肾损害的临床研究[J].中华内科杂志,2005,44(4):262-264. 被引量：42
  • 3杨晓媛,曲黎,曹广顺.温阳化饮通络法治疗心肾综合征31例[J].陕西中医,2007,28(6):659-660. 被引量：28
  • 4Ronco C,McCullough P, Anker SD,et al. Cardio-renalsyndromes : report from the consensus conference of the acutedialysis quality initiative [J]. Eur Heart J, 2010,31(6): 703-711.
  • 5Ronco C,Haapio M, House AA, et al. Cardiorenal syndrome[J]. J Am Coll CardioU2008,52(19) :1527-1539.
  • 6Hebert K,Dias A,Delgado MC,et al. Epidemiology and ’survival of the five stages of chronic kidney disease in a systolicheart failure population[J], Eur J Heart Fail,2010,12(8) :861-865.
  • 7Smith GL,Lichtman JH,Bracken MB,et al. Renal impairmentand outcomes in heart failure: systematic review and meta-analysis[J]. J Am Coll Cardiol,2006,47.10) : 1987-1996.
  • 8Kazory A. Need for a unified decision-making tool forultrafiltration therapy in heart failure: call for action[J]. AmHeart J,2010,159(4) :505-507.
  • 9Bart BA. Treatment of congestion in congestive heart failure:ultrafiltration is the only rational initial treatment of volumeoverload in decompensated heart failure[J]. Circ Heart Fail,2009,2(5):499-504.
  • 10Udani SM,Murray PT. The use of renal replacement therapyin acute decompensated heart failure[J]. Semin Dial, 2009,22 .(2):173-179.

引证文献5

二级引证文献19

中华保健医学杂志
2012年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部